AlphaStar Capital Management LLC bought a new position in BlackRock Health Sciences Trust (NYSE:BME – Free Report) during the fourth quarter, Holdings Channel.com reports. The fund bought 23,139 shares of the company’s stock, valued at approximately $878,000.
Several other institutional investors and hedge funds have also added to or reduced their stakes in BME. Janney Montgomery Scott LLC grew its holdings in shares of BlackRock Health Sciences Trust by 40.5% in the 4th quarter. Janney Montgomery Scott LLC now owns 32,787 shares of the company’s stock worth $1,244,000 after acquiring an additional 9,455 shares during the last quarter. Fountainhead AM LLC acquired a new position in shares of BlackRock Health Sciences Trust in the third quarter worth about $204,000. Wolverine Asset Management LLC raised its holdings in shares of BlackRock Health Sciences Trust by 42.4% during the third quarter. Wolverine Asset Management LLC now owns 85,565 shares of the company’s stock valued at $3,588,000 after acquiring an additional 25,457 shares during the period. Consolidated Portfolio Review Corp lifted its position in shares of BlackRock Health Sciences Trust by 7.2% in the 3rd quarter. Consolidated Portfolio Review Corp now owns 42,574 shares of the company’s stock valued at $1,785,000 after acquiring an additional 2,853 shares in the last quarter. Finally, International Assets Investment Management LLC acquired a new position in BlackRock Health Sciences Trust in the 3rd quarter worth approximately $8,610,000.
BlackRock Health Sciences Trust Stock Performance
BME opened at $40.64 on Friday. BlackRock Health Sciences Trust has a 12-month low of $36.87 and a 12-month high of $42.75. The stock has a fifty day moving average of $39.17 and a 200-day moving average of $40.46.
BlackRock Health Sciences Trust Dividend Announcement
BlackRock Health Sciences Trust Profile
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Further Reading
- Five stocks we like better than BlackRock Health Sciences Trust
- What is an Earnings Surprise?
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
- The Significance of Brokerage Rankings in Stock Selection
- Why New Tariffs Could Boost These 3 Basic Materials Stocks
- 3 Dividend Kings To Consider
- MarketBeat Week in Review – 02/03 – 02/07
Want to see what other hedge funds are holding BME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust (NYSE:BME – Free Report).
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.